Journals / Turkish Journal of Immunology / 2020 / Cilt: 8 - Sayı: 2

Impact of Storage Period on CD4+/CD8+ T Lymphocyte Ratio in Erythrocyte Suspensions

Eritrosit Süspansiyonlarında Depolanma Sürecinin CD4+/CD8+ T Lenfositleri Oranı Üzerine Etkisi

Pages
44–49
Publication Date
2022-11-06
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Decrease of CD3 (p=0,001), CD4 (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Some immunologic changes in the recipient derived by allogeneic blood transfusion (ABT) are called Transfusion Related Immune Modulation (TRIM).
📊
Key Findings & Data:Despite the exact mechanisms of these changes are not known, it is thought that ABT causes a decrease of CD4/CD8 ratio in the recipient.
💡
Conclusion & Impact:Decrease of CD3 (p=0,001), CD4 (p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Some immunologic changes in the recipient derived by allogeneic blood transfusion (ABT) are called Transfusion Related Immune Modulation (TRIM). Despite the exact mechanisms of these changes are not known, it is thought that ABT causes a decrease of CD4/CD8 ratio in the recipient. This study aimed to determine the CD4/CD8 ratio in stored erythrocyte suspensions (ES) and to obtain new information about TRIM mechanisms. Materials and Methods: Whole blood components used in our study were collected from 10 healthy volunteers. ES’ obtained from whole blood were divided into three equal aliquots. Test samples which were related to 0th, 21st and 42nd storage days were prepared from these aliquots. CD3, CD4 and CD8 surface markers in peripheral blood mononuclear cells were investigated with flow-cytometer in these test samples. Results: Our data were evaluated according to storage days. Decrease of CD3 (p=0,001), CD4 (p

Özet

Giriş: Allojeneik kan transfüzyonunun (AKT) alıcıda neden olduğu bazı immünolojik değişikliklere transfüzyonla ilişkili immunomodülasyon (TRIM) adı verilmektedir. Bu değişikliklerin mekanizması tam olarak bilinmese de, AKT’nin alıcının mononülear kan hücrelerindeki CD4/CD8 ifadesi oranında azalmaya yol açtığına inanılmaktadır. Bu çalışmada depolanan eritrosit süspansiyonlarından elde edilen mononükleer hücrelerdeki (ES) CD4/CD8 ifadesi oranını belirlemek ve TRIM mekanizmalarına yönelik yeni bilgiler edinmek amaçlanmıştır. Gereç ve Yöntemler: Çalışmamızda kullanılan tam kanlar sağlıklı 10 gönüllüden elde edilmiştir. Bu tam kanlardan elde edilen ES’ler eşit üç parçaya bölünmüş ve ES’lerin 0, 21 ve 42. raf günlerine yönelik test örnekleri bu parçalardan elde edilmiştir. Test örneklerdeki CD3, CD4 ve CD8 yüzey belirteçleri akan hücre ölçer yardımıyla incelenmiştir. Bulgular: Verilerimiz ES’lerin depolanma günlerine gore değerlendirilmiştir. Sıfırıncı gün örneklerine göre 21. gün örneklerinde CD3 (p=0,001), CD4 (p

🔖

Cite This Article

CAN, F. E., HEPER, Y., BAL, S. H., KUMAŞ, L. T., BUDAK, F., GÖRAL, G., ORAL, H. B. (2022). Impact of Storage Period on CD4+/CD8+ T Lymphocyte Ratio in Erythrocyte Suspensions. Turkish Journal of Immunology, Cilt: 8 - Sayı: 2, 44–49. https://ajindex.com/articles/607173

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Opelz G, Sengar DP, Mickey MR, Terasaki PI. Effect of blood transfusions on subsequent kidney transplants. Transplant Proc 1973;5:253–9
  2. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007;21:327–48
  3. Bal SH, Oral HB. Transfusion Related Immunomodulation. Turk J Immunol 2016;4:37–46
  4. Blajchman MA, Bordin JO. Mechanisms of transfusion-associated immunosuppression. Curr Opin Hematol 1994;1:457–61
  5. Brunson ME, Alexander JW. Mechanisms of transfusion-induced immunosuppression. Transfusion 1990;30:651–8
  6. Bilgin YM, van de Watering LM, Eijsman L, Versteegh MI, Brand R, van Oers MHJ, Brand A. Double-blind, randomized controlled trial on the effect of leukocyte-depleted erythrocyte transfusions in cardiac valve surgery. Circulation 2004;109:2755–60
  7. Koch CG, Li L, Sessler DI, Figueroa P, Hoeltge GA, Mihaljevic T, Blackstone EH. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 2008;358:1229–39
  8. Goel R, Johnson DJ, Scott AV, Tobian AA, Ness PM, Nagababu E, Frank SM. Red blood cells stored 35 days or more are associated with adverse outcomes in high-risk patients. Transfusion 2016;56:1690–8
  9. Rapido F, Brittenham GM, Bandyopadhyay S, La Carpia F, L’Acqua C, McMahon DJ, et al. Prolonged red cell storage before transfusion increases extravascular hemolysis. J Clin Invest 2017;127:375–82
  10. Offner PJ, Moore EE, Biffl WL, Johnson JL, Silliman CC. Increased rate of infection associated with transfusion of old blood after severe injury. Arch Surg 2002;137:711–6; discussion 716–7
  11. Kaplan J, Sarnaik S, Gitlin J, Lusher J. Diminished helper/ suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 1984;64:308–10
  12. Chen G, Zhang FJ, Gong M, Yan M. Effect of perioperative autologous versus allogeneic blood transfusion on the immune system in gastric cancer patients. J Zhejiang Univ Sci B 2007;8:560–5
  13. Gafter U, Kalechman Y, Sredni B. Induction of a subpopulation of suppressor cells by a single blood transfusion. Kidney Int 1992;41:143–8
  14. Kessler CM, Schulof RS, Goldstein AL, Naylor PH, Luban NL, Kelleher JF, Reaman GH. Abnormal T-lymphocyte subpopulations associated with transfusion of blood-derived products. Lancet 1983;321:991–2
  15. Sirchia G, Mercuriali F, Pizzi C, Rosso di San Secondo VE, Borzini P, Aniasi A. Blood transfusion and kidney transplantation: effect of small doses of blood on kidney graft f